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 1 
Abstract 1 
Objective To compare the clinical effects of alfaxalone, ketamine and propofol in dogs 2 
following premedication with medetomidine and methadone. 3 
Study design Prospective, ‘blinded’ and randomized clinical study. 4 
Animals Seventy-five male dogs presented for neutering at a charity clinic. 5 
Methods Dogs were allocated to receive alfaxalone, ketamine or propofol following 6 
premedication with medetomidine (20 µg kg-1) and methadone (0.2 mg kg-1). Dogs were 7 
temperament scored prior to premedication. Quality of sedation, induction of 8 
anaesthesia, recovery and recovery environment were scored by simple descriptive 9 
scales. Physiological variables during anaesthesia were recorded. Continuous numerical 10 
data were analysed using ANOVA with repeated measures as necessary. Non-11 
parametric data were analysed using Kruskal-Wallis tests and multiple comparisons 12 
using Dunn’s test. Statistical significance was set at p < 0.05. 13 
Results The mean (± SD) dose of alfaxalone was 0.6 ± mg kg-1, ketamine 1.5 ± 0.7 mg 14 
kg-1and 0.8 ± 0.3 mg kg-1 for propofol. Alfaxalone inductions were significantly 15 
smoother compared to ketamine but not to propofol. Only 1 of 75 of the inductions were 16 
deemed poor. There were no differences in cardiopulmonary variables between groups 17 
except immediately after induction of anaesthesia. There were no differences in quality 18 
of recovery between groups. 19 
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 2 
Conclusions and clinical relevance All three induction agents provided reliable, 20 
predictable anaesthesia conditions that were clinically indistinguishable and ideal for 21 
teaching anaesthesia skills. The medetomidine and methadone premedication resulted in 22 
profound, heavy sedation and quality of induction of anaesthesia was better with 23 
alfaxalone compared to ketamine. No significant difference in induction quality was 24 
detected between alfaxalone and proprofol or propofol and ketamine, and these findings 25 
are likely to be of limited clinical significance when choosing an induction agent.  26 
 27 
 28 
Keywords alfaxalone, anaesthesia, dog, ketamine, propofol  29 
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 3 
Introduction 30 
Alfaxalone, propofol and ketamine are all used as intravenous induction agents in the 31 
dog with differing popularity. The true differences between the three induction agents 32 
alfaxalone, ketamine and propofol following an alpha 2 agonist/opioid premedication is 33 
not known. The effects of these induction drugs may be overstated during anaesthesia 34 
teaching, because they are often used concurrently with other agents reducing the 35 
potential discriminating properties. There are many factors that can affect the quality of 36 
induction and recovery, namely behaviour and/or temperament of the dogs, 37 
premedication, anaesthetic protocol, postoperative pain, and ambient environment. The 38 
choice of premedication can dramatically affect the anaesthetic induction, maintenance, 39 
and recovery. It is uncommon nowadays in clinical studies to use an induction agent 40 
without premedication in view of the benefits that preemptive analgesia, anxiolysis and 41 
sedation confer on the animal and the handlers. Favourable reports of the sedation 42 
afforded by methadone and low dose medetomidine have been reported (Puighibet et al. 43 
2015). 44 
Studies undertaken in children have shown that anxiety and temperament can influence 45 
the quality of recovery, with intense preoperative anxiety predisposing to a restless 46 
recovery from anaesthesia (Vlajkovic & Sindjelic 2007). One canine study however 47 
demonstrated that the behaviour of the dogs did not significantly influence the recovery 48 
phase (Jiménez et al. 2012). Dogs judged to be calm and of a happy demeanour scored 49 
equally on the simple descriptive scale (SDS) and the visual analogue scale (VAS) 50 
compared to nervous dogs during recovery. The kennel environment is also presumed to 51 
affect the patients’ emergence and comfort in the recovery period. There remains the 52 
assumption that a quiet and stress free environment will enhance recovery. No studies 53 
have evaluated these factors in detail, but a few reports include the level of noise in the 54 
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recovery area (Jiménez et al. 2012; Mathis et al. 2012) and Mathis and co-workers 55 
concluded that the noise was probably of limited significance in two populations of cats 56 
recovering after alfaxalone or propofol (Mathis et al. 2012).  57 
In practice, the choice of any protocol should be at the discretion of the veterinary 58 
surgeon, and this decision should be evidence based rather than opinion based. In an 59 
environment where teaching of anaesthesia takes place, there is the need for the 60 
instructors to offer an unbiased appraisal of the evidence, ample opportunity for 61 
acquisition of practical skills coupled with patient safety. During the final year of 62 
training of veterinary students there is a requirement to ensure students become 63 
effective, and skills must be actively taught rather than acquired through reading or 64 
traditional didactic teaching. One crucial factor in developing expertise is the deliberate 65 
practice undertaken (Ericsson 2007) and it is imperative that students have ample 66 
opportunities to deliberate practice in a safe supportive environment. In addition to 67 
deliberate practice, real-time feedback and time for problem-solving plus opportunities 68 
for repeated performance to refine behaviour will ensure the experiential learning is 69 
optimized and go some way to ensuring that student becomes a self-regulated learner 70 
(Ericsson 2015).  71 
This study had two aims, firstly, the major aim was to evaluate whether the choice of 72 
induction agent had an impact on the quality of induction, maintenance, and recovery in 73 
healthy dogs undergoing anaesthesia for castration. A secondary aim was to evaluate the 74 
suitability of different protocols for the teaching of anaesthesia and surgery to final year 75 
veterinary students and consider the experiential learning. 76 
 77 
Materials and methods 78 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 5 
The study was carried out at RSPCA Greater Manchester Animal Hospital. Ethical 79 
approval was granted prior to the study by the University of Nottingham ethics 80 
committee (Ref 1424 150325) and informed owner consent was obtained prior to 81 
enrolment. A pilot study was undertaken. A sample size calculation indicated that 25 82 
dogs per group would be required to show a statistically significant difference. It was 83 
estimated that the size of the sample should be of at least 75 dogs to have an 80% power 84 
and 95% confidence level of detecting a 25% difference in induction and recovery 85 
scores as assessed by a four point simple descriptive scale (SDS) based on a pilot study, 86 
using an ordinal logistic regression model relying on a proportional odds assumption.  87 
 88 
Animals  89 
Seventy-five male dogs were enrolled in the study (71 were client owned and 4 RSPCA 90 
dogs being neutered prior to rehoming). All owners were participating in a heavily 91 
discounted neutering scheme offered by the RSPCA Greater Manchester Animal 92 
Hospital.  On admission, dogs were examined and assigned American Society of 93 
Anesthesiologists (ASA) status, and a temperament score on a four point simple 94 
descriptive scale adapted from previous studies with categories of 1) calm; 2) happy; 3) 95 
nervous; and 4) aggressive (Jiménez et al. 2012).  96 
Exclusion criteria were ASA status > II, dogs weighing greater than 50kg or less than 2 97 
kg, dogs with abnormal testicular pathology or cryptorchidism. 98 
 99 
Sedation protocol 100 
Dogs were fasted overnight and had free access to water up until the time of 101 
premedication. 102 
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 6 
All dogs were weighed and received premedication based on bodyweight of a mixture 103 
of 20 µg kg-1medetomidine (Sedator; Dechra, UK) and 0.2 mg kg-1 methadone 104 
(Comfortan; Dechra) intramuscularly (IM) into the quadriceps muscle. Following 105 
premedication all dogs were left undisturbed for 15 minutes and the degree of sedation 106 
was scored using a modified numeric rating scale based on previous studies (Gurney et 107 
al. 2009; Maddern et al. 2010). Sedation was categorized as: 1) Profound/Heavy, 108 
impossible to arouse; 2) Good, heavily sedated but possible to arouse when stimulated; 109 
3) Moderate, moderate sedated and easily aroused with minimal stimulation; 4) 110 
Inadequate, no apparent effect of the premedication and no indication of sedation; 5) 111 
Excited, more difficult to handle than prior to premedication. 112 
Induction of anaesthesia 113 
Dogs were allocated using a random number generator (www.randomizer.org) to one of 114 
the following three groups alfaxalone (Alfaxan; Jurox, UK), ketamine (Anesketin; 115 
Dechra) or propofol (PropoFlo Plus; Zoetis, UK) and induction drugs were administered 116 
intravenously (IV) over 60 seconds by final year veterinary students. Incremental doses, 117 
if required, were only administered after 60 seconds had elapsed. Dogs’ tracheas were 118 
intubated with an appropriate sized cuffed endotracheal tube. The dose of induction 119 
agent and quality of induction and recovery was recorded by a scorer unaware of the 120 
induction agent used, using a modified numeric rating scale used in a feline study 121 
(Mathis et al. 2012) Induction score were categorized as: 1) Very smooth, with gradual 122 
patient relaxation, no movement or vocalization and first intubation attempt successful; 123 
2) Good, some swallowing, coughing, tongue or jaw movement, and a slight degree of 124 
physical movement; 3) Poor, swallowing, coughing, some distress or excitement; 4) 125 
Very poor, major distress or excitement. Isoflurane (Isoflo; Zoetis) in oxygen was 126 
delivered via an appropriately sized breathing system (circle or Ayre’s T-piece with 127 
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 7 
Jackson Rees modification). All animals were allowed to breathe spontaneously. 128 
Following orotracheal intubation all dogs received 0.2 mg kg -1 meloxicam (Metacam; 129 
Boehringer-Ingelheim, UK) subcutaneously and amoxicillin (Betamox; Norbrook, UK) 130 
15 mg kg -1 IM. All dogs underwent castration surgery on heated operating tables 131 
(Burtons, UK).  132 
Maintenance of anaesthesia 133 
Clinical criteria used to assess depth included respiratory rate [fR (calculated manually 134 
from observing chest excursions)], pulse rate [PR (calculated manually from recording 135 
pulse rate over 15 seconds)], eye position, palpebral reflex, jaw tone and spontaneous 136 
movement. Other parameters recorded included vaporizer setting and incidence of 137 
apnoea (defined as cessation of respiratory movements >60 seconds). All dogs were 138 
monitored continuously and parameters recorded at 5-minute intervals. Rectal 139 
temperature was recorded prior to recovery. 140 
Recovery 141 
At the end of the surgical procedures the isoflurane was discontinued, dogs were 142 
extubated and the quality of recovery assessed by using a simple descriptive scale by a 143 
scorer unaware of the induction agent, with categories 1) Very smooth, no excitement, 144 
trembling, paddling or vocalization; 2) Smooth, some excitement or paddling or 145 
vocalization on recovery; 3) Poor, sustained vocalization, paddling or excitement on 146 
recovery; 4) Very poor, extreme excitement, paddling, vocalization with risk of injury, 147 
intervention necessary. The noise in the recovery area was also described (Appendix A). 148 
Behavioural scores and mentation scores were recorded on discharge.  149 
Student experience 150 
Informal feedback about the surgical and anaesthesia experience was gained from 151 
veterinary nurses and students involved in the study. 152 
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 153 
Statistical analyses 154 
Statistical tests were performed using GraphPad Prism (GraphPad Software, CA, USA) 155 
version 6. Continuous numerical data sets were tested for normality using the 156 
D’Agostino Pearson test and analyzed using the analysis of variance (ANOVA) and 157 
with repeated measures as necessary. Multiple comparisons were performed if the 158 
ANOVA showed significance. Normally distributed data are presented as mean ± 159 
standard deviation (SD). Non-parametric data were analyzed using Kruskal-Wallis tests 160 
and multiple comparisons using Dunn’s test. Non-parametric data are presented as 161 
median (interquartile range). Categorical (ordinal) data are reported as mean proportions 162 
within each category for each induction drug and compared using logistic regression 163 
analyses with an ordinal scale. Results were considered significant when p < 0.05.  164 
 165 
Results 166 
Animals 167 
A total of 75 dogs weighing 11.2 (2.0 – 46.5) kg were recruited and randomly allocated 168 
to receive one of three induction agents. All dogs completed the study. There were no 169 
significant differences in weights and temperaments between the three groups. The 170 
demographic data from the three groups are presented in Table 1.  171 
Sedation 172 
Time from premedication to induction of anaesthesia, PR after premedication and 173 
sedation scores were not significantly different between groups (Table 2).  174 
Induction 175 
The subjective quality of induction was significantly different between the groups. Only 176 
1 of 75 of the inductions were deemed poor and this was following propofol. Alfaxalone 177 
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 9 
inductions were significantly smoother (p = 0.003) compared to ketamine but not to 178 
propofol (Fig. 1). The alfaxalone group had the most scores of 1 (very smooth 179 
induction) (Table 2). The dose of alfaxalone for induction was 0.6 ± 0.2 mg kg-1, and 180 
for ketamine 1.5 ± 0.7 mg kg-1 and for propofol 0.8 ± 0.3 mg kg-1.  181 
Pain on injection was noted in 2 of 75 dogs, one whilst receiving alfaxalone and one 182 
whilst receiving ketamine.  183 
Maintenance of anaesthesia  184 
Apnoea lasting longer than 60 seconds was noted on 4 occasions in dogs receiving 185 
propofol (n=3) and ketamine (n=1). Vaporizer settings ranged between 0.5 ̶ 1.5 % for 186 
dogs on T piece breathing systems and 1.0 ̶ 2.0% on circle breathing systems. There was 187 
no significant difference between the three groups for vaporizer setting in animals using 188 
the same breathing systems. No dogs required additional increments of induction agents 189 
during anaesthesia. 190 
Pulse rates were significantly different between groups at 5 minutes after induction 191 
(Table 2). There was no significant difference in pulse rates between groups before 192 
induction (p = 0.916) or at any time points after 5 minutes or over time from induction 193 
to 60 minutes (p = 0.511) (Fig. 2). 194 
Respiratory rates were not significant different between groups, but were significantly 195 
different over time from induction to 60 minutes (p=0.001). 196 
Recovery 197 
Recovery data were unremarkable between groups with no difference in duration of 198 
anaesthesia, surgery, recovery scores or environmental noise in the recovery area. One 199 
dog in the propofol group vomited in recovery. All but two dogs (which remained in the 200 
hospital as they were to be rehomed) were discharged within several hours of 201 
extubation, and the dog’s preanaesthetic demeanour compared with its post anaesthetic 202 
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demeanour. No reversal of the alpha-2 agonist was performed or considered necessary. 203 
Two dogs that were frightened, aggressive and uncooperative on admission were 204 
discharged uneventfully and deemed no longer to showing the same behaviours. A 205 
small number of dogs from all groups were slightly sedated on discharge. There was no 206 
difference in mentation scores at discharge between groups (Table 2). 207 
Temperature was not significantly different between groups at the end of the procedure.  208 
Student experience 209 
All students were able to induce anaesthesia without intervention from the instructor. In 210 
cases of perivascular administration of the induction agents, all students were successful 211 
with subsequent attempts under close supervision and encouragement. In all cases 212 
where tracheal intubation failed, students were able to identify the mistake, rectify the 213 
situation and went on to successfully intubate the patient with no untoward effects. 214 
Transition to inhalational agent was uneventful in all cases and no patients required 215 
incremental doses of induction agent. One student was responsible for the surgery and 216 
one for the anaesthesia for each patient under the supervision of the instructor. Informal 217 
feedback from students highlighted opportunity to compare and contrast different 218 
induction agents, gain confidence with their use, refine and improve practical skills in 219 
an unhurried and supportive environment in healthy animals, and was compared by 220 
them to their experiential learning in other intra and extra mural studies. 221 
 222 
Discussion  223 
Anaesthetic protocols 224 
All three induction agents provided very similar anaesthetic profiles. The profound 225 
sedation that was achieved in most dogs in this study will have in part contributed to the 226 
relatively small doses of induction agent required for induction of anaesthesia and 227 
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endotracheal intubation. Raekallio and co-workers concluded that the hypoxaemia 228 
following IV 0.02 mg kg-1 medetomidine and 0.1 mg kg-1 L-methadone (and 229 
fenpipramide) limited the clinical usefulness of the combination at those dosages 230 
(Raekallio et al. 2009) however our study used IM administration and this will have 231 
altered the peak effect and bioavailability of the drug (Dyck et al. 1993). All but one of 232 
the dogs in this study were ASA I, and a possible short lived degree of hypoxaemia 233 
would have likely caused minimal clinical signs and adverse effects, however an alpha 234 
2 agonist and opioid combination may cause respiratory depression and hypoxaemia 235 
and patients should be regularly assessed and some may benefit from oxygen 236 
supplementation (Enouri et al. 2008). Doses of the induction agent were substantially 237 
reduced from data sheet dosages and serve to illustrate the magnitude of possible dose 238 
sparing that the premedication drugs afford. The ketamine and propofol doses were 239 
similar to other studies using medetomidine and hydromorphone premedication (Enouri 240 
et al. 2008). The reduction of the data sheet alfaxalone dose from 2 mg kg-1 to the dose 241 
used in this study 0.6 mg kg-1 demonstrates the necessity to titrate the induction drug to 242 
effect to avoid overdose.  243 
Adverse events 244 
The number of adverse events in this study was very few (1 incidence of vomiting on 245 
extubation in the propofol group, and 1 dog per group exhibiting profound bradycardia, 246 
and pain on injection in two dogs receiving ketamine and alfaxalone) in contrast to 247 
similar studies. The most likely explanation is the premedication protocol. The 248 
incidence of adverse events that occurred during the induction phase was less than other 249 
investigations of anaesthetic induction with alfaxalone (Muir et al. 2008) propofol 250 
(Sano et al. 2003a; Sano et al. 2003b) and ketamine (White et al. 2001). This may be 251 
attributed to the relatively profound sedation thereby limiting the effect the induction 252 
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agent contributed. No dogs demonstrated cyanosis or unexpected respiratory depression 253 
following premedication.  254 
Student experience 255 
These anaesthesia conditions contributed to a learning environment where students 256 
could proceed methodically, cautiously without undue haste and/or pressure. This 257 
profound sedation provided excellent conditions for IV administration of agents. The IV 258 
administration of induction agent was undertaken by final year veterinary students 259 
without complication, demonstrating that venous access was not so compromised 15 260 
minutes after administration of the alpha 2 agent so as to hinder intravenous 261 
administration of drugs. Students appreciated the operative conditions, and were able to 262 
easily secure IV access, induce a plane of anaesthesia suitable for intubation, intubate 263 
carefully and slowly, with multiple attempts where necessary, secure the airway and 264 
maintain anaesthesia and recording parameters in a logical, considered manner.  265 
The operative conditions facilitated a calm and low stress teaching environment 266 
conducive to affording the students ample time to safely carry out all stages of 267 
anaesthesia process, allowing supervised mistakes and feedback to occur whilst still 268 
maintaining a high standard of patient care. Training in practical skills such as securing 269 
intravenous access and airway management are essential components of any veterinary 270 
anaesthesia curriculum and whilst didactic teaching remains important it is no substitute 271 
for hands on practice. Nevertheless, it oftentimes difficult to ensure sufficient exposure 272 
to healthy normal patients undergoing anaesthesia such that every student can practise 273 
these core skills in a controlled supportive environment. The combinations in this study 274 
afforded such conditions and exposed students to three different induction agents to 275 
compare operative conditions. Usually students are trained using part task trainers for 276 
tasks such as intravenous access and intubation and may then use high fidelity 277 
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simulators designed to reproduce the task in a veterinary context. Whilst unproven this 278 
approach is considered to aid in honing technical, cognitive and decision making skills, 279 
but still falls short of training on live patients. It is necessary that those involved in 280 
teaching anaesthesia can plan to provide opportunities that meet the student needs rather 281 
than teaching whilst providing a service on inappropriate patients. The combinations 282 
used in this study afforded an excellent teaching environment, and illustrated that 283 
differences between agents were clinically difficult to detect.  284 
Limitations 285 
One of the limitations of this study was the lack of more comprehensive monitoring 286 
during anaesthesia, and in view of this it is impossible to comment for example on the 287 
effect the drugs on blood pressure; the operative conditions however were simulated to 288 
represent typical primary care practice for the students. Areas for future research 289 
included the assessment of methods of teaching veterinary anaesthesia to students and 290 
veterinary surgeons. 291 
Conclusions 292 
We conclude, all three induction agents provide consistent, reproducible, and clinically 293 
similar conditions following medetomidine and methadone premedication highly 294 
suitable for teaching and assessing anaesthesia procedural skills.   295 
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Figure legends  
 
 
Figure 1 Induction of anaesthesia scores for dogs that had received alfaxalone (n=25), 
ketamine (n=25) or propofol (n=25). Induction of anaesthesia was significantly 
smoother following alfaxalone (p = 0.003). 
 
Figure 2 Pulse rates [median (range)] in dogs following induction of anaesthesia with 
alfaxalone, ketamine or propofol (n = 25 in each group). For drug doses see Table 2. 
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Table 1 Clinical details of 75 dogs undergoing anaesthesia for castration randomly 
allocated to receive alfaxalone, ketamine or propofol as induction agents. Data are 
presented as median (interquartile range) or number of dogs. 
 
 Group 
Alfaxalone Ketamine Propofol 
ASA status (I:II) 25:0 24:1 25:0 
Body mass (kg) 13 (7 ̶ 27) 10 (6 ̶ 22) 11 (6 ̶ 18) 
Age (months) 50 (10 ̶ 84) 31 (10 ̶ 44) 28 (8 ̶ 48) 
Temperament Score  1 (1 ̶ 2) 1 (1 ̶ 2) 2 (1 ̶ 3) 
 
Breed  
American Bulldog 0 0 1 
Bichon Frise 2 1 0 
Border Terrier 1 0 0 
Basset hound 0 2 0 
Beagle 0 0 1 
Border Collie 1 0 0 
Boxer 0 1 0 
Cocker Spaniel 4 1 0 
Cairn Terrier 0 1 0 
Chinese Crested  0 1 0 
Chihuahua 2 1 0 
Cavalier King Charles 0 1 0 
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Spaniel 
Dalmatian 0 0 1 
French Bulldog 0 0 1 
German Shepherd Dog 2 2 0 
Jack Russell Terrier 0 1 1 
Labrador 0 1 0 
Lhasa Apso 1 0 0 
Pug 1 0 0 
Rottweiler 1 0 1 
Staffordshire Bull 
Terrier 
3 3 4 
Shi Tzu 0 4 1 
Tibetan Terrier 0 0 1 
Cross bred 5 4 10 
Yorkshire Terrier 2 3 1 
    
ASA, American Society of Anesthesiologists 
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e, 
ex
pre
sse
d a
s m
ed
ian
 (i
nte
rqu
art
ile
 ra
ng
e) 
in 
75
 do
gs
 pr
em
ed
ica
ted
 w
ith
 m
ed
eto
mi
din
e a
nd
 m
eth
ad
on
e a
nd
 in
du
ce
d w
ith
 ei
the
r a
lfa
xa
lon
e, 
ke
tam
ine
 or
 pr
op
ofo
l f
or 
ca
str
ati
on
. T
he
 do
se 
of 
ind
uc
tio
n a
ge
nt 
is 
ex
pre
sse
d a
s m
ea
n ±
 st
an
da
rd 
de
via
tio
n. 
  
Al
fax
alo
ne
 
Ke
tam
ine
 
Pr
op
ofo
l 
p v
alu
e  
Se
da
tio
n S
co
re 
 
1 (
1 ̶ 
2) 
1 (
1) 
1 (
1 ̶ 
2) 
0.1
18
 
Pr
e-i
nd
uc
tio
n p
uls
e r
ate
 (b
ea
ts 
mi
nu
te-
1 ) 
 
56
 (4
5 ̶ 
62
) 
54
 (4
1 ̶ 
65
) 
56
 (4
6 ̶ 
60
) 
0.9
94
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st-
ind
uc
tio
n p
uls
e r
ate
 be
ats
 m
inu
te-
1 ) 
 
55
 (5
0 ̶ 
62
) 
65
 (6
1 ̶ 
80
) 
57
 (4
4 ̶ 
64
) 
0.0
03
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me
 fr
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em
ed
ica
tio
n t
o i
nd
uc
tio
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(m
inu
tes
) 
24
 (2
1 ̶ 
31
) 
22
 (1
92
 ̶ 9
) 
20
 (1
5 ̶ 
29
) 
0.3
67
 
Ind
uc
tio
n S
co
re 
 
1 (
1 ̶ 
1) 
2 (
1 ̶ 
2) 
1 (
1 ̶ 
1) 
0.0
03
 
Do
se 
of 
ind
uc
tio
n a
ge
nt 
(m
g k
g -
1 ) 
0.6
 ± 
0.2
 
1.5
 ± 
0.7
 
0.8
 ± 
0.3
 
N/
A 
Re
co
ve
ry 
sco
re 
 
2 (
1 ̶ 
2) 
2 (
1 ̶ 
2) 
2 (
1 ̶ 
2) 
0.8
92
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C
C
EP
TE
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A
N
U
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R
IP
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Te
mp
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tur
e o
n r
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ov
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 C
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37
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 0.
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6 
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inu
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 (4
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0) 
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 (4
9-7
2) 
0.3
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ion
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 an
ae
sth
esi
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nu
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) 
72
 (6
6-8
5) 
69
 (5
7-8
3) 
84
 (6
7-9
6) 
0.1
58
 
Re
co
ve
ry 
en
vir
on
me
nt 
no
ise
 sc
ore
 
3 (
3-4
) 
3 (
3-4
) 
3 (
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) 
0.7
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Appendix A Description of the noise in the recovery environment 
 
 
Categories Description 
1 No noise  
2 Small amount of noise Personnel entering and leaving the ward 
but no conversation or other significant 
noise 
3 Moderate amount Personnel entering and leaving the ward, 
some conversation  
4 Very noisy Loud conversation, constant noise, dogs 
barking/whining, radio playing loudly 
  
